These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9167769)

  • 1. Histologic differences in benign prostate hyperplasia between Chinese and American men.
    Yu EY; Siegal JA; Meyer GE; Ji XR; Ni XZ; Brawer MK
    Prostate; 1997 May; 31(3):175-9. PubMed ID: 9167769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia.
    Shapiro E; Becich MJ; Hartanto V; Lepor H
    J Urol; 1992 May; 147(5):1293-7. PubMed ID: 1373778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
    Cadeddu JA; Pearson JD; Lee BR; Landis P; Partin AW; Epstein JI; Carter HB
    Urology; 1995 May; 45(5):795-800. PubMed ID: 7538241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate.
    Babinski MA; Chagas MA; Costa WS; Sampaio FJ
    BJU Int; 2003 Oct; 92(6):592-6. PubMed ID: 14511041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the cellular composition of benign prostatic hyperplasia in Chinese and Caucasian-American men.
    Lepor H; Shapiro E; Wang B; Liang YC
    Urology; 1996 Jan; 47(1):38-42. PubMed ID: 8560660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphometric quantitation of stroma in human benign prostatic hyperplasia.
    Deering RE; Bigler SA; King J; Choongkittaworn M; Aramburu E; Brawer MK
    Urology; 1994 Jul; 44(1):64-70. PubMed ID: 7518983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascularity in benign prostatic hyperplasia.
    Deering RE; Bigler SA; Brown M; Brawer MK
    Prostate; 1995 Mar; 26(3):111-5. PubMed ID: 7534916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometry of the prostate: I. Distribution of tissue components in hyperplastic glands.
    Marks LS; Treiger B; Dorey FJ; Fu YS; deKernion JB
    Urology; 1994 Oct; 44(4):486-92. PubMed ID: 7524234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
    Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
    Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.
    Matsuda T; Fujime M; Suda K
    Anal Quant Cytol Histol; 2006 Jun; 28(3):121-4. PubMed ID: 16786720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary study of the frequency of benign prostatic hyperplasia and prostatic cancer in China.
    Gu FL; Xia TL; Kong XT
    Urology; 1994 Nov; 44(5):688-91. PubMed ID: 7526525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen.
    Song L; Zhu Y; Han P; Chen N; Lin D; Lai J; Wei Q
    Urology; 2011 Mar; 77(3):688-92. PubMed ID: 20974483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percentage area density of epithelial and mesenchymal components in benign prostatic hyperplasia: comparison of results between single biopsy, multiple biopsies and multiple tissue specimens.
    Robert M; Costa P; Bressolle F; Mottet N; Navratil H
    Br J Urol; 1995 Mar; 75(3):317-24. PubMed ID: 7537601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in cellular composition of benign prostatic hyperplasia.
    Aoki Y; Arai Y; Maeda H; Okubo K; Shinohara K
    Prostate; 2001 Dec; 49(4):243-50. PubMed ID: 11746270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
    Claus S; Berges R; Senge T; Schulze H
    J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
    Schulze H; Barrack ER
    Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
    Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
    Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond.
    Montironi R; Valli M; Fabris G
    J Clin Pathol; 1996 Apr; 49(4):324-8. PubMed ID: 8655710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between the quantitative morphometry and the clinical response to alpha adrenergic blocker in benign prostatic hyperplasia].
    Sakai S; Shimazaki J
    Nihon Hinyokika Gakkai Zasshi; 1996 Mar; 87(3):695-701. PubMed ID: 8709447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative proportions of tissue components in the prostate: are they related to the development of symptomatic BPH in Korean men?
    Byun SS; Jeong H; Jo MK; Lee E
    Urology; 2005 Sep; 66(3):593-6. PubMed ID: 16140084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.